Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 3373-53-3 | MDL No. : | MFCD00142931 |
Formula : | C5H5N5O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DRAVOWXCEBXPTN-UHFFFAOYSA-N |
M.W : | 151.13 | Pubchem ID : | 76900 |
Synonyms : |
Crotonoside;2-Oxoadenine;NSC 241501;2-Hydroxyadenine;2-hydroxy-6-Aminopurine
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 38.91 |
TPSA : | 100.45 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -8.39 cm/s |
Log Po/w (iLOGP) : | 0.49 |
Log Po/w (XLOGP3) : | -1.65 |
Log Po/w (WLOGP) : | -0.76 |
Log Po/w (MLOGP) : | -1.31 |
Log Po/w (SILICOS-IT) : | 0.6 |
Consensus Log Po/w : | -0.53 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.34 |
Solubility : | 68.6 mg/ml ; 0.454 mol/l |
Class : | Very soluble |
Log S (Ali) : | 0.05 |
Solubility : | 170.0 mg/ml ; 1.13 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | -1.7 |
Solubility : | 3.04 mg/ml ; 0.0201 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.83 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 14047-28-0 ]
(R)-1-(6-Amino-9H-purin-9-yl)propan-2-ol
Similarity: 0.66
[ 3240-72-0 ]
5,6-Diaminopyrimidine-2,4-diol
Similarity: 0.63
[ N/A ]
2-Amino-1,5-dihydropteridin-4-ol
Similarity: 0.60
[ 16017-76-8 ]
2-Chloro-7-methyl-7H-purin-6-ol
Similarity: 0.59
[ 6055-72-7 ]
7H-Purin-6-amine hydrochloride hydrate (2:2:1)
Similarity: 0.85
[ 6055-72-7 ]
7H-Purin-6-amine hydrochloride hydrate (2:2:1)
Similarity: 0.85